Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan

Jun Kido, Shirou Matsumoto, Johannes Häberle, Yukihiro Inomata, Mureo Kasahara, Seisuke Sakamoto, Reiko Horikawa, Akihiro Tanemura, Hideaki Okajima, Tatsuya Suzuki, Kimitoshi Nakamura

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Urea cycle disorders (UCDs) are inherited metabolic diseases causing hyperammonemia by defects in urea cycle enzymes or transporters. Liver transplantation (LT) currently is the only curative treatment option until novel therapies become available. We performed a nationwide questionnaire-based study between January 2000 and March 2018 to investigate the effect of LT in patients with UCDs in Japan. A total of 231 patients with UCDs were enrolled in this study. Of them, a total of 78 patients with UCDs (30 male and 16 female ornithine transcarbamylase deficiency (OTCD), 21 carbamoyl phosphate synthetase 1 deficiency (CPSD), 10 argininosuccinate synthetase deficiency (ASSD) and 1 arginase 1 deficiency (ARGD)) had undergone LT. Concerning the maximum blood ammonia levels at the onset time in the transplanted male OTCD (N = 28), female OTCD (N = 15), CPSD (N = 21) and ASSD (N = 10), those were median 634 (IQR: 277-1172), 268 (211-352), 806 (535-1382), and 628 (425-957) μmol/L, respectively. The maximum blood ammonia levels in female OTCD were thus significantly lower than in the other UCDs (all P <.01). LT was effective for long-term survival, prevented recurrent hyperammonemia attack, and lowered baseline blood ammonia levels in patients with UCDs. LT had limited effect for ameliorating neurodevelopmental outcome in patients with severe disease because hyperammonemia at the onset time already had a significant impact on the brain. Patients with ASSD may be more likely to survive without cognitive impairment by receiving early LT despite severe neonatal hyperammonemia ≥ 360 μmol/L. In patients with neonatal onset OTCD or CPSD, there may be additional factors with adverse effects on the brain that are not improved by LT.

Original languageEnglish
Pages (from-to)1311-1322
Number of pages12
JournalJournal of Inherited Metabolic Disease
Volume44
Issue number6
DOIs
Publication statusPublished - 11-2021

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan'. Together they form a unique fingerprint.

Cite this